Validation of the Wild-type Influenza A Human Challenge Model H1N1pdMIST: An A(H1N1)pdm09 Dose-Finding Investigational New Drug Study-Reference-Cited by-同舟云学术

Validation of the Wild-type Influenza A Human Challenge Model H1N1pdMIST: An A(H1N1)pdm09 Dose-Finding Investigational New Drug Study

Published:2014-11-20 Issue:5 Volume:60 Page:693-702
ISSN:1537-6591
Container-title:Clinical Infectious Diseases
language:en
Short-container-title:

Author:

Memoli Matthew J.,Czajkowski Lindsay,Reed Susan,Athota Rani,Bristol Tyler,Proudfoot Kathleen,Fargis Sarah,Stein Matthew,Dunfee Rebecca L.,Shaw Pamela A.,Davey Richard T.,Taubenberger Jeffery K.

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

Link

http://academic.oup.com/cid/article-pdf/60/5/693/17854256/ciu924.pdf

Reference37 articles.

1. H7N9 avian influenza A virus and the perpetual challenge of potential human pandemicity;Morens;mBio,2013

2. Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans;Garten;Science,2009

3. Estimates of deaths associated with seasonal influenza—United States, 1976–2007;Centers for Disease C, Prevention;MMWR Morb Mortal Wkly Rep,2010

4. Newer influenza antivirals, biotherapeutics and combinations;Hayden;Influenza Other Respir Viruses,2013

5. Experimental human influenza: observations from studies of influenza antivirals;Hayden;Antivir Ther,2012

Cited by 136 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Astodrimer Sodium Nasal Spray versus Placebo in Non-Hospitalised Patients with COVID-19: A Randomised, Double-Blinded, Placebo-Controlled Trial;Pharmaceutics;2024-09-06

2. Symptom propagation in respiratory pathogens of public health concern: a review of the evidence;Journal of The Royal Society Interface;2024-07

3. Safety, tolerability, viral kinetics, and immune correlates of protection in healthy, seropositive UK adults inoculated with SARS-CoV-2: a single-centre, open-label, phase 1 controlled human infection study;The Lancet Microbe;2024-07

4. Prevalence of anti-lymphocyte IgM autoantibodies driving complement activation in COVID-19 patients;Frontiers in Immunology;2024-04-17

5. Mucosal correlates of protection after influenza viral challenge of vaccinated and unvaccinated healthy volunteers;mBio;2024-02-14